Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
暂无分享,去创建一个
F. Shuaib | Heather M. Scobie | C. Ihekweazu | O. Bolu | R. Tohme | Melissa M. Coughlin | Qian An | Ifedayo M. O. Adetifa | O. Okunromade | G. Cooley | A. Egwuenu | Nishanth Parameswaran | Bassey Okposen | Ridwan Yahaya | B. Lawal | Temitope Olaleye | Ndodo Nnaemeka | T. Jegede
[1] A. Tatem,et al. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria , 2022, medRxiv.
[2] J. Mosser,et al. Factors consistently associated with utilisation of essential maternal and child health services in Nigeria: analysis of the five Nigerian national household surveys (2003–2018) , 2022, BMJ Open.
[3] A. Tatem,et al. Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria , 2022, PloS one.
[4] Nicole A. Hoff,et al. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014 , 2022, PloS one.
[5] M. Levine,et al. Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach , 2021, Vaccine.
[6] Heather M. Scobie,et al. Validation of a diphtheria toxoid multiplex bead assay for serosurveys. , 2021, Diagnostic microbiology and infectious disease.
[7] J. Ostermann,et al. Parental concerns and uptake of childhood vaccines in rural Tanzania – a mixed methods study , 2020, BMC Public Health.
[8] P. Adrien,et al. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017. , 2020, The American journal of tropical medicine and hygiene.
[9] Antoine Durupt,et al. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018 , 2019, The Journal of infectious diseases.
[10] E. Mworozi,et al. Barriers to effective uptake and provision of immunization in a rural district in Uganda , 2019, PloS one.
[11] Heather M. Scobie,et al. Integrated Serologic Surveillance of Population Immunity and Disease Transmission , 2018, Emerging infectious diseases.
[12] P. Offit,et al. Plotkin's Vaccines , 2017 .
[13] Heather M. Scobie,et al. Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique. , 2017, The American journal of tropical medicine and hygiene.
[14] Y. Woldeamanuel,et al. Case fatality of adult tetanus in Africa: Systematic review and meta-analysis , 2016, Journal of the Neurological Sciences.
[15] F. Cutts,et al. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.
[16] R. Baggaley,et al. Tetanus disease and deaths in men reveal need for vaccination , 2016, Bulletin of the World Health Organization.
[17] K. Wannemuehler,et al. Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012 , 2016, Clinical and Vaccine Immunology.
[18] C Jessica E Metcalf,et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease , 2016, The Lancet.
[19] James D. Campbell,et al. Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia , 2016, PloS one.
[20] N. Basta,et al. Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Yuxiao Tang,et al. MenAfriVac as an Antitetanus Vaccine , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] V. Dietz,et al. Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys. , 2014, Vaccine.
[23] K. Porten,et al. Diphtheria outbreak with high mortality in northeastern Nigeria , 2013, Epidemiology and Infection.
[24] R. Oladokun,et al. Re-emergence of diphtheria and pertussis: implications for Nigeria. , 2012, Vaccine.
[25] Richard G Pebody,et al. Immunity to tetanus and diphtheria in the UK in 2009. , 2012, Vaccine.
[26] A. Glatman-Freedman,et al. The effect of social determinants on immunization programs , 2012, Human vaccines & immunotherapeutics.
[27] M. Préziosi,et al. The Meningitis Vaccine Project. , 2007, Vaccine.
[28] K. Kjeldsen,et al. Immunity to tetanus and diphtheria in rural Africa. , 1997, The American journal of tropical medicine and hygiene.
[29] K. A. Harrison,et al. Trade Flows and Employment Outcomes in Nigeria , 2010 .
[30] J. Meigs,et al. WHO Technical Report , 1954, The Yale Journal of Biology and Medicine.
[31] Module,et al. The Immunological Basis for Immunization Series , 2000 .
[32] Epidemic meningitis control in countries of the African meningitis belt, 2016. , 2017, Releve epidemiologique hebdomadaire.
[33] The immunological basis for immunization series Module , 2009 .
[34] M. Deming,et al. Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. , 2002, Bulletin of the World Health Organization.
[35] Tigran Nikoghosyan,et al. United Nations Children’s Fund (UNICEF) , 2018, Yearbook of International Cooperation on Environment and Development 1998–99.